MX9204279A - Tiazolidindionas hipoglicemicas e intermediarios. - Google Patents

Tiazolidindionas hipoglicemicas e intermediarios.

Info

Publication number
MX9204279A
MX9204279A MX9204279A MX9204279A MX9204279A MX 9204279 A MX9204279 A MX 9204279A MX 9204279 A MX9204279 A MX 9204279A MX 9204279 A MX9204279 A MX 9204279A MX 9204279 A MX9204279 A MX 9204279A
Authority
MX
Mexico
Prior art keywords
thiazolidindionas
intermediarios
hipoglicemicas
ethers
alcohols
Prior art date
Application number
MX9204279A
Other languages
English (en)
Spanish (es)
Inventor
David A Clark
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9204279A publication Critical patent/MX9204279A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
MX9204279A 1991-07-22 1992-07-21 Tiazolidindionas hipoglicemicas e intermediarios. MX9204279A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73377191A 1991-07-22 1991-07-22

Publications (1)

Publication Number Publication Date
MX9204279A true MX9204279A (es) 1994-03-31

Family

ID=24949048

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9204279A MX9204279A (es) 1991-07-22 1992-07-21 Tiazolidindionas hipoglicemicas e intermediarios.

Country Status (19)

Country Link
US (1) US6329408B1 (esLanguage)
EP (1) EP0641338A1 (esLanguage)
JP (1) JPH08823B2 (esLanguage)
CN (1) CN1030195C (esLanguage)
AU (1) AU665775B2 (esLanguage)
BR (1) BR9206293A (esLanguage)
CA (1) CA2111447C (esLanguage)
CZ (1) CZ282831B6 (esLanguage)
HU (1) HUT69692A (esLanguage)
IE (1) IE922357A1 (esLanguage)
IL (1) IL102573A (esLanguage)
MX (1) MX9204279A (esLanguage)
NO (1) NO301226B1 (esLanguage)
NZ (1) NZ243653A (esLanguage)
PT (1) PT100711B (esLanguage)
RU (1) RU2079497C1 (esLanguage)
TW (1) TW222626B (esLanguage)
WO (1) WO1993002079A1 (esLanguage)
ZA (1) ZA925468B (esLanguage)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI940306L (fi) * 1991-07-22 1994-01-21 Pfizer Menetelmä kiraalisten tiatsolidiini-2,4-dionijohdannaisten synteesissä tarvittavien välituotteiden valmistamiseksi
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
CZ299310B6 (cs) 1997-06-18 2008-06-18 Smithkline Beecham Plc Lécivo pro lécbu diabetes mellitus a stavu spojených s diabetes mellitus
AR023699A1 (es) 1998-11-12 2002-09-04 Smithkline Beecham Corp Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica
DE69939485D1 (de) 1998-11-12 2008-10-16 Smithkline Beecham Plc Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin
YU72201A (sh) * 1999-04-28 2005-07-19 Aventis Pharma Deutschland Gmbh. Derivati di-aril kiseline kao ppar receptorski ligandi
TWI302149B (en) * 1999-09-22 2008-10-21 Bristol Myers Squibb Co Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
HK1045991B (en) * 1999-11-10 2004-12-10 Takeda Pharmaceutical Company Limited 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
MXPA02011609A (es) * 2000-05-26 2003-03-27 Nippon Shinyaku Co Ltd Compuestos heterociclicos.
GB0014969D0 (en) 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
JP2003040877A (ja) * 2001-07-24 2003-02-13 Sumika Fine Chemicals Co Ltd 5−[6−(2−フルオロベンジルオキシ)−2−ナフチル]メチル−2,4−チアゾリジンジオンの製造方法及びその精製方法
SG154333A1 (en) * 2002-06-03 2009-08-28 Novartis Ag The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
CN100402510C (zh) * 2002-07-03 2008-07-16 霍夫曼-拉罗奇有限公司 噁唑衍生物及其作为胰岛素敏化剂的应用
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US8268352B2 (en) 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
BRPI0414580A (pt) * 2003-09-22 2006-11-07 Ono Pharmaceutical Co derivado do ácido fenilacético, processos para sua produção e uso
DE602004004631D1 (de) * 2004-04-01 2007-03-22 Sanofi Aventis Deutschland Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
US20120094959A1 (en) 2010-10-19 2012-04-19 Bonnie Blazer-Yost Treatment of cystic diseases
WO2016071727A1 (en) 2014-11-04 2016-05-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the prevention and the treatment of rapidly progressive glomerulonephritis
CN109867765A (zh) * 2019-02-28 2019-06-11 中山大学惠州研究院 一种长效缓释可降解防污聚氨酯及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
US4342771A (en) 1981-01-02 1982-08-03 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4367234A (en) 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4617312A (en) 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones
CN1003445B (zh) 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
HU210339B (en) 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
FI91869C (fi) * 1987-03-18 1994-08-25 Tanabe Seiyaku Co Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
GB8713861D0 (en) * 1987-06-13 1987-07-15 Beecham Group Plc Compounds
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
US5036079A (en) 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents

Also Published As

Publication number Publication date
NO940225D0 (no) 1994-01-21
CN1068823A (zh) 1993-02-10
RU2079497C1 (ru) 1997-05-20
CN1030195C (zh) 1995-11-01
NZ243653A (en) 1995-02-24
IL102573A (en) 1997-04-15
TW222626B (esLanguage) 1994-04-21
AU2297392A (en) 1993-02-23
JPH07502487A (ja) 1995-03-16
CA2111447A1 (en) 1993-02-04
NO940225L (no) 1994-01-21
IL102573A0 (en) 1993-01-14
PT100711B (pt) 1999-07-30
CZ282831B6 (cs) 1997-10-15
IE922357A1 (en) 1993-01-27
WO1993002079A1 (en) 1993-02-04
JPH08823B2 (ja) 1996-01-10
AU665775B2 (en) 1996-01-18
ZA925468B (en) 1994-01-21
PT100711A (pt) 1993-09-30
CA2111447C (en) 2002-08-13
EP0641338A1 (en) 1995-03-08
CZ12494A3 (en) 1994-07-13
BR9206293A (pt) 1994-11-08
HUT69692A (en) 1995-09-28
HU9400181D0 (en) 1994-05-30
NO301226B1 (no) 1997-09-29
US6329408B1 (en) 2001-12-11

Similar Documents

Publication Publication Date Title
MX9204279A (es) Tiazolidindionas hipoglicemicas e intermediarios.
ES2071169T3 (es) 1-indolilalquil-4-(alcoxi-pirimidinil)piperazinas.
FI92652C (fi) Suodatuskynttilä
ES2184797T3 (es) Uso de antagonistas de serotonina (5ht3) para el tratamiento de la fibromialgia.
ES2119762T3 (es) Tratamiento de la catarata con la ayuda de derivados 15-ceto-prostaglandinas.
DE69319692D1 (de) Superfluoreszierende Quelle
DE3587102D1 (de) Superstrahlungslichtquelle.
DE69326496D1 (de) Ringförmige Röntgenstrahlenquelle
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
FI931486L (fi) Daeckuppsaettning foer fordon som koers pao snoeiga och isiga vaegar
ES2139024T3 (es) Produccion de xilitol por recombinacion y huesped utilizado para este procedimiento.
IT8224890A0 (it) Procedimento litografico per la fabbricazione di fibre ottiche.
ES2093099T3 (es) Preparacion de piperidinas sustituidas.
AR007770A1 (es) Nuevos diamino pirazoles, su sintesis, composiciones de tintura de fibras queratinicas que los contienen, procedimientos de tintura de fibrasqueratinicas.
DE69301977D1 (de) Superfluoreszierende Quelle
MX9101254A (es) Medios para el cultivo de celulas de insectos
ES2048793T3 (es) Antibioticos antifungicos.
FI962481A0 (fi) 4-bentsoyyli-isokatsolit ja niiden käyttö herbisideinä
ES2133342T3 (es) Agentes microbicidas.
ES2058319T3 (es) Nuevos-(imino sustituido)-1,3,4-dihidrotiadiazoles.
ES535757A0 (es) Procedimiento para la obtencion de alcoxiaril-alcanoles
DK0915858T3 (da) Mellemprodukter til fremstilling af 2-imidazolin-5-oner
MX174317B (es) Procedimiento para la preparacion de 1-hidroximetilpirazoles
ES2060944T3 (es) Derivados de 2,5,6,7-tetranor-4,8-inter-m-fenileno de pgi2 (prostaglandina i2).
ES2120483T3 (es) Alcoholes benzilo y benzhidrilo.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees